
Background: Legionella pneumophila is the causative agent of legionellosis and is primarily associated with L. pneumophila serogroup 1 (Lp1). Strains reactive with the monoclonal antibody (mAb) 3/1 are associated with higher virulence and are predominantly responsible for clinical cases. The reactivity with mAb 3/1 correlates with the presence of the lag-1 gene, encoding an O-acetyltransferase that modifies lipopolysaccharides on the bacterial membrane. Despite its clinical importance, rapid and reliable tools for detecting lag-1 + strains are limited. Objectives: We aimed to develop and validate a quantitative real-time PCR (qPCR) assay targeting the lag-1 gene for detecting mAb 3/1 + L. pneumophila strains. Methods: Primers and probes were designed to amplify all known lag-1 allelic variants. The assay was validated with regard to specificity, sensitivity, limit of detection (LoD), and quantification (LoQ). Clinical evaluation was performed on 249 respiratory samples, comparing lag-1 qPCR results with mAb-based typing results, especially reactivity with mAb 3/1, of isolates and whole genome sequencing. Results: The qPCR assay demonstrated complete concordance and amplified all lag-1 variants without cross-reactivity during validation. The LoD was 10 GU/reaction, and the LoQ was 50 GU/reaction. Using clinical samples, the assay showed a sensitivity of 95.48% and a specificity of 98.58% compared with mAb-based typing. From 248 specimens, 239 showed a complete concordance between the lag-1 qPCR and mAb-typing Conclusion: The lag-1 qPCR assay offers a culture-independent, rapid, and sensitive method for detecting virulent mAb 3/1 + L. pneumophila strains. This tool has the potential to enhance diagnostic workflows and guide public health interventions by integrating virulence markers into risk assessment protocols.
Objectives: To characterize the genomic profiles of sporadic urogenital Neisseria meningitidis isolates and expand the limited data on this emerging infection. Methods: Comparative genomic analysis was performed to investigate the diversity and clonal relationships of urogenital Neisseria meningitidis isolates in Meizhou, China. Two sporadic isolates, designated MZ01 and MZ02, were recovered from urethral secretions of male patients with urethral infection in 2022. These isolates were subjected to whole-genome sequencing alongside publicly available genomes from the PubMLST database. Sequence types were determined by multilocus sequence typing. Minimum spanning tree, core-genome single nucleotide polymorphism (cgSNP), and norB-aniA comparative analyses were conducted to characterize lineage-specific genetic features. Results: The isolates belonged to distinct sequence types (ST-5881 for MZ01 and ST-11026 for MZ02). cgSNP analysis showed MZ01 to be highly divergent from all public genomes and MZ02 closely related to NML2024–119 and the Chinese urogenital isolate Nm521, suggesting distinct clonal origins. MZ01 harbored a serogroup B capsule synthesis locus, whereas MZ02 had a ctrA/ctrB deletion, suggesting a capsule-null genotype. Both carried meningococcus-type norB-aniA profiles distinct from the gonococcal-type cassette of US_NmUC. Both isolates showed penicillin resistance and ceftriaxone susceptibility, with MZ02 additionally resistant to ciprofloxacin and trimethoprim-sulfamethoxazole, consistent with gyrA and folP mutations. Conclusions: This study provides a limited but informative genomic snapshot of sporadic urogenital Neisseria meningitidis isolates from Meizhou, China. Although based on only two isolates with limited clinical metadata, the distinct lineages observed underscore the need for continued surveillance.
Objectives To characterize the genomic profiles of sporadic urogenital Neisseria meningitidis isolates and expand the limited data on this emerging infection. Methods Comparative genomic analysis was performed to investigate the diversity and clonal relationships of urogenital Neisseria meningitidis isolates in Meizhou, China. Two sporadic isolates, designated MZ01 and MZ02, were recovered from urethral secretions of male patients with urethral infection in 2022. These isolates were subjected to whole-genome sequencing alongside publicly available genomes from the PubMLST database. Sequence types were determined by multilocus sequence typing. Minimum spanning tree, core-genome single nucleotide polymorphism (cgSNP), and norB-aniA comparative analyses were conducted to characterize lineage-specific genetic features. Results The isolates belonged to distinct sequence types (ST-5881 for MZ01 and ST-11026 for MZ02). cgSNP analysis showed MZ01 to be highly divergent from all public genomes and MZ02 closely related to NML2024–119 and the Chinese urogenital isolate Nm521, suggesting distinct clonal origins. MZ01 harbored a serogroup B capsule synthesis locus, whereas MZ02 had a ctrA/ctrB deletion, suggesting a capsule-null genotype. Both carried meningococcus-type norB-aniA profiles distinct from the gonococcal-type cassette of US_NmUC. Both isolates showed penicillin resistance and ceftriaxone susceptibility, with MZ02 additionally resistant to ciprofloxacin and trimethoprim-sulfamethoxazole, consistent with gyrA and folP mutations. Conclusions This study provides a limited but informative genomic snapshot of sporadic urogenital Neisseria meningitidis isolates from Meizhou, China. Although based on only two isolates with limited clinical metadata, the distinct lineages observed underscore the need for continued surveillance.
Background The German National Reference Centre for multidrug-resistant Gram-negative bacteria at the Department of Medical Microbiology of the Ruhr University Bochum offers the free service of carbapenemase detection or confirmation to German laboratories in order to obtain molecular surveillance data on the spread of carbapenemases in Germany. To prevent capacity overload, the NRC had to sharpen the submission criteria in march 2025 to achieve a better pre-selection of isolates submitted and eventually reduce the number of isolates analyzed. Methods Species identification was performed using MALDI-TOF MS. Carbapenemase detection was performed using a set of phenotypic assays and PCRs targeting the common carbapenemase genes in Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii, followed by sequencing of PCR products for allele identification and Illumina whole genome sequencing when indicated. Results Compared to 2024, the number of isolates submitted for carbapenemase detection decreased by 18.6% to 8307. Carbapenemase detections on the other hand increased by 13% to 6.058. The major carbapenemases in Enterobacterales were OXA-48, OXA-244, NDM-5, NDM-1, KPC-2 and VIM-1, while in P. aeruginosa, VIM-2 predominated and OXA-23 and OXA-72 were the most prevalent carbapenemases identified in A. baumannii. The proportion of carbapenemase-positive isolates increased significantly, especially for isolates of P. aeruginosa and Enterobacter cloacae complex. Conclusions The sharpened submission criteria led to a drop in isolates sent for analysis in 2025. Nonetheless, the number of carbapenemase-positive isolates increased significantly compared to 2024, indicating that the changed criteria had no negative impact on sensitivity, but a positive effect on specificity for carbapenemase production. This alarming observation indicates that carbapenemases are increasingly spreading in Germany.